KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Return on Capital Employed (2016 - 2025)

Travere Therapeutics (TVTX) has disclosed Return on Capital Employed for 12 consecutive years, with 0.15% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed rose 78.0% year-over-year to 0.15%, compared with a TTM value of 0.15% through Dec 2025, up 78.0%, and an annual FY2025 reading of 0.14%, up 52.0% over the prior year.
  • Return on Capital Employed was 0.15% for Q4 2025 at Travere Therapeutics, up from 0.22% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.15% in Q4 2025 and bottomed at 1.06% in Q3 2024.
  • Average Return on Capital Employed over 5 years is 0.53%, with a median of 0.49% recorded in 2022.
  • The sharpest move saw Return on Capital Employed plummeted -33bps in 2022, then skyrocketed 84bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.31% in 2021, then tumbled by -107bps to 0.63% in 2022, then fell by 0bps to 0.63% in 2023, then crashed by -46bps to 0.93% in 2024, then soared by 84bps to 0.15% in 2025.
  • Business Quant data shows Return on Capital Employed for TVTX at 0.15% in Q4 2025, 0.22% in Q3 2025, and 0.48% in Q2 2025.